Medical News

RSS

Perrigo's ANDA for Ketoconazole Foam, 2% receives final FDA approval to treat seborrheic dermatitis

Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for Ketoconazole Foam, 2%, the generic version of Extina Ketoconazole Foam, 2%.

31 Aug 2011

Favorable top-line results from Aeterna Zentaris' AEZS-130 Phase 3 study on AGHD

Aeterna Zentaris Inc. today announced favorable top-line results of its completed Phase 3 study with AEZS-130 as the first oral diagnostic test for Adult Growth Hormone Deficiency.

31 Aug 2011

Omega board authorizes repurchase of $100M shares of common stock

Omega Healthcare Investors, Inc., announced today that its Board of Directors has authorized the repurchase of up to $100 million of its outstanding common stock, from time to time over the next 12 months.

31 Aug 2011

Viewpoints: States' anti-abortion laws; unproven cancer therapy; paying for retirees' health benefits

Since last year, 13 states, including Kansas, have enacted laws banning insurance coverage of abortion in the health insurance exchanges created by the federal health care reform law. Some states have gone even further, aggressively restricting abortion coverage even in private insurance plans sold outside the exchanges. ... These cases, some of which are being appealed, are testing whether the antiabortion movement will get its way. It shouldn't.

31 Aug 2011

Racial, ethnic and poverty disparities in human papillomavirus vaccination completion

Barriers that hinder young African-American, Hispanic and poor women from completing a series of three vaccinations to prevent human papillomavirus infection (HPV) also leave them at higher risk for cervical cancer and death.

30 Aug 2011

Study finds alarming results about parents' beliefs on importance of sleep in their children's lives

A study conducted by The Better Sleep Council and The Sleep Council found alarming results about parents' beliefs on the importance of sleep in their children's lives, aged 7-18.

30 Aug 2011

Stereotaxis reaffirms commercialization plans for Epoch, Odyssey platforms into standard labs

The Board of Directors of Stereotaxis, Inc. announced today following its regularly scheduled board meeting that it reaffirmed the Company's plans for both the launch of the Epoch platform and expansion of the Odyssey platform into standard labs.

30 Aug 2011

Results of Aeterna Zentaris' AEZS-131 anticancer Erk inhibitor presented at ACS 2011 meeting

Aeterna Zentaris Inc. today announced that a poster on its novel orally active anticancer Erk inhibitor, which includes AEZS-131, was presented at the 242nd American Chemical Society National Meeting held at the Colorado Convention Center in Denver, Colorado.

30 Aug 2011

Biophysicists discover how to turn body's own resistance to radiation treatment on and off

Radiation can make cancer cells resistant to radio- and chemotherapy. University of Oslo researchers have now figured out how resistance can be switched on and off.

30 Aug 2011

Alcon chooses Bruker ContourGT-X8 Optical Surface Profiler

Bruker announced today that Alcon Corporation has selected the Bruker ContourGT-X8 Optical Surface Profiler to provide non-destructive, non-contact reference metrology for critical dimensioning and 3D characterization of Alcon's current and next-generation intra-ocular lenses.

From Bruker Nano Surfaces and Metrology 30 Aug 2011

EMD Millipore announces acquisition of Amnis

EMD Millipore, the Life Science division of Merck KGaA of Germany, today announced it has agreed to acquire Seattle-based Amnis Corporation. Amnis designs, manufactures and markets high speed cell imaging instrumentation.

30 Aug 2011

Invacare announces winners of Real Life campaign contest

Invacare Corporation, the global leader in the manufacture and distribution of home and long-term care medical products, today announced the winners of its Real Life campaign contest.

30 Aug 2011

Streamline Health receives Drummond Group's ONC-ATCB certification for AccessAnyWare v5.1

Streamline Health Solutions, Inc., a leading provider of enterprise and departmental document management solutions and business process workflows for healthcare, announced today that AccessAnyWare v5.1 has received the federal government's "meaningful use" stamp of approval by earning modular inpatient EHR certification for the following requirements: 170.302 O-V and 170.306 E, H.

30 Aug 2011

Avantra is now Courtagen Life Sciences

Avantra Biosciences Corporation today announced that effective immediately it is changing its name to Courtagen Life Sciences, Inc. The company will continue to use the Avantra name for their proteomics portfolio, which includes the Avantra Biomarker System.

30 Aug 2011

FDA accepts Salix and Progenics' sNDA filing for RELISTOR to treat opioid-induced constipation

Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.

30 Aug 2011

EMD Millipore acquires Amnis

Amnis Corporation, a manufacturer of advanced cell imaging systems, today announced that the company has been acquired by EMD Millipore, the Life Science division of Merck KGaA of Germany.

30 Aug 2011

First Edition: August 30, 2011

Today's headlines include a report about a new federal and state program that will apply scrutiny to any health-premium increase of more than 10 percent.

30 Aug 2011

Study may help explain plague's rapid evolution and aid in development of therapeutics

In the evolutionary blink of an eye, a bacterium that causes mild stomach irritation evolved into a deadly assassin responsible for the most devastating pandemics in human history. How did the mild-mannered Yersinia pseudotuberculosis become Yersinia pestis, more commonly known as the Plague?

30 Aug 2011

Bristol-Myers Squibb selects ICON as preferred provider for early phase clinical development

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been chosen by Bristol-Myers Squibb Company as a preferred provider for full-service clinical pharmacology and exploratory clinical studies.

30 Aug 2011

ZIOPHARM initiates ZIN ATI-001 Phase 1 clinical study in advanced melanoma

ZIOPHARM Oncology, Inc. today announced that the first patient has been dosed in a Phase 1 clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate, in patients with advanced melanoma.

30 Aug 2011

Medical News

Perrigo's ANDA for Ketoconazole Foam, 2% receives final FDA approval to treat seborrheic dermatitis

Favorable top-line results from Aeterna Zentaris' AEZS-130 Phase 3 study on AGHD

Omega board authorizes repurchase of $100M shares of common stock

Viewpoints: States' anti-abortion laws; unproven cancer therapy; paying for retirees' health benefits

Racial, ethnic and poverty disparities in human papillomavirus vaccination completion

Study finds alarming results about parents' beliefs on importance of sleep in their children's lives

Stereotaxis reaffirms commercialization plans for Epoch, Odyssey platforms into standard labs

Results of Aeterna Zentaris' AEZS-131 anticancer Erk inhibitor presented at ACS 2011 meeting

Biophysicists discover how to turn body's own resistance to radiation treatment on and off

Alcon chooses Bruker ContourGT-X8 Optical Surface Profiler

EMD Millipore announces acquisition of Amnis

Invacare announces winners of Real Life campaign contest

Streamline Health receives Drummond Group's ONC-ATCB certification for AccessAnyWare v5.1

Avantra is now Courtagen Life Sciences

FDA accepts Salix and Progenics' sNDA filing for RELISTOR to treat opioid-induced constipation

EMD Millipore acquires Amnis

First Edition: August 30, 2011

Study may help explain plague's rapid evolution and aid in development of therapeutics

Bristol-Myers Squibb selects ICON as preferred provider for early phase clinical development

ZIOPHARM initiates ZIN ATI-001 Phase 1 clinical study in advanced melanoma

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News